Detall de la convocatòria
Característiques
Característica |
---|
Objectiu de la convocatòria
Bayer's mission is to provide new treatment options for diseases with high unmet medical need. Bayer HealthCare offers grants for researchers investigating novel drug targets in the fields of the indications listed below to promote innovative therapeutic ideas from basic research into novel drugs. It provides financial support to test your hypothesis, start or extend your present research activities. |
Característiques principals
Target must be a nucleic acid or a protein (e.g. an enzyme, a receptor) whose activity can be modified by a drug Target should have shown to be effective/ mechanistically involved in the disease by relevant in vitro or in vivo models. Target is disease-modifying and/or has a proven function in the pathophysiology of a disease. Types of grants: Grant types do not need to be selected by the grant applicant. |
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76. Marta López: mlopez4@imim.es Ext.: 1576 Carol Barnwell: cbarnwell@imim.es Ext.: 1670 |
Convocatòria (URL)
https://grants4targets.bayer.com/home/pharma/ |
Requisits
Researchers from universities, other academic research institutes and start-up companies from all over the world are eligible. |
Dotació
Two types of grants: |
Documentació
Grant applications can only be submitted via the electronic submission platform. It is only necessary to provide an abstract describing your idea and target, its characteristics and a separate description of its therapeutic potential, and a CV and relevant publications. Please note that only non-confidential information should be provided. http://mc.manuscriptcentral.com/grants4targets |
Arxius
Arxiu |
---|
Grants4Targets - Pharmaceuticals.pdf |